Cargando…

Efficacy of weekly teriparatide does not vary by baseline fracture probability calculated using FRAX

SUMMARY: The aim of this study was to determine the efficacy of once-weekly teriparatide as a function of baseline fracture risk. Treatment with once-weekly teriparatide was associated with a statistically significant 79 % decrease in vertebral fractures, and in the cohort as a whole, efficacy was n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Harvey, N. C., Kanis, J. A., Odén, A., Nakamura, T., Shiraki, M., Sugimoto, T., Kuroda, T., Johansson, H., McCloskey, E. V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer London 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4532707/ https://www.ncbi.nlm.nih.gov/pubmed/26092062 http://dx.doi.org/10.1007/s00198-015-3129-7

Ejemplares similares

FRAX™ and the assessment of fracture probability in men and women from the UK
por: Kanis, J. A., et al.
Publicado: (2008)

Treatment responses with once-weekly teriparatide therapy for osteoporosis
por: Shiraki, M., et al.
Publicado: (2016)

FRAX-based fracture probabilities in South Africa
por: Johansson, Helena, et al.
Publicado: (2021)

Adjusting FRAX Estimates of Fracture Probability Based on a Positive Vertebral Fracture Assessment
por: Ye, Carrie, et al.
Publicado: (2023)

Falls Predict Fractures Independently of FRAX Probability: A Meta‐Analysis of the Osteoporotic Fractures in Men (MrOS) Study
por: Harvey, Nicholas C, et al.
Publicado: (2017)

Menopausal hormone therapy reduces the risk of fracture regardless of falls risk or baseline FRAX probability—results from the Women’s Health Initiative hormone therapy trials
por: Lorentzon, Mattias, et al.
Publicado: (2022)

A surrogate FRAX model for the Kyrgyz Republic
por: Lesnyak, O., et al.
Publicado: (2020)

Temporal changes in access to FRAX® in Thailand between 2010 and 2018
por: Chotiyarnwong, Pojchong, et al.
Publicado: (2019)

Epidemiology of hip fracture and the development of a FRAX model for Uzbekistan
por: Lesnyak, O, et al.
Publicado: (2020)

Epidemiology of hip fracture and the development of FRAX in Ukraine
por: Povoroznyuk, VV, et al.
Publicado: (2017)

A surrogate FRAX model for Pakistan
por: Naureen, G., et al.
Publicado: (2021)

Once-weekly teriparatide administration for 24 weeks in postmenopausal women with osteoporosis: reply to T. Kawada
por: Sugimoto, T., et al.
Publicado: (2014)

FRAX-Based Intervention Thresholds for Osteoporosis Treatment in Ukraine
por: Povoroznyuk, Vladyslav, et al.
Publicado: (2021)

Effect of abaloparatide on vertebral, nonvertebral, major osteoporotic, and clinical fractures in a subset of postmenopausal women at increased risk of fracture by FRAX probability
por: McCloskey, E. V., et al.
Publicado: (2019)

A new FRAX model for Brazil
por: Albergaria, B. H., et al.
Publicado: (2023)

A country-specific FRAX model for Botswana
por: Kebaetse, M., et al.
Publicado: (2021)

Epidemiology of osteoporotic fracture in Kazakhstan and development of a country specific FRAX model
por: Issayeva, S., et al.
Publicado: (2020)

Renal Phosphate Reabsorption is Correlated with the Increase in Lumbar Bone Mineral Density in Patients Receiving Once-Weekly Teriparatide
por: Takeuchi, Yasuhiro, et al.
Publicado: (2015)

A systematic review of hip fracture incidence and probability of fracture worldwide
por: Kanis, J. A., et al.
Publicado: (2012)

Development and application of a Japanese model of the WHO fracture risk assessment tool (FRAX™)
por: Fujiwara, S., et al.
Publicado: (2008)

Epidemiology of hip fractures in Bulgaria: development of a country-specific FRAX model
por: Kirilova, E., et al.
Publicado: (2020)

Profile of changes in bone turnover markers during once-weekly teriparatide administration for 24 weeks in postmenopausal women with osteoporosis
por: Sugimoto, T., et al.
Publicado: (2013)

Epidemiology of osteoporotic fracture in Moldova and development of a country-specific FRAX model
por: Zakroyeva, Alla, et al.
Publicado: (2020)

Global impact of COVID-19 on non-communicable disease management: descriptive analysis of access to FRAX fracture risk online tool for prevention of osteoporotic fractures
por: McCloskey, E. V., et al.
Publicado: (2020)

Incidence of hip fracture in Saudi Arabia and the development of a FRAX model
por: Saleh, Yousef A. L., et al.
Publicado: (2022)

Hemoglobin Levels Improve Fracture Risk Prediction in Addition to FRAX Clinical Risk Factors and Bone Mineral Density
por: Jaiswal, Raju, et al.
Publicado: (2023)

Management of Patients With High Baseline Hip Fracture Risk by FRAX Reduces Hip Fractures—A Post Hoc Analysis of the SCOOP Study
por: McCloskey, Eugene, et al.
Publicado: (2018)

Epidemiology of fractures in Armenia: development of a country-specific FRAX model and comparison to its surrogate
por: Lesnyak, O., et al.
Publicado: (2017)

Epidemiology of hip fracture in Qatar and development of a country specific FRAX model
por: Abdulla, Nabeel, et al.
Publicado: (2022)

Use of age-dependent FRAX-based intervention thresholds for Singapore
por: Kanis, John A., et al.
Publicado: (2020)

New simulation model for bone formation markers in osteoporosis patients treated with once-weekly teriparatide
por: Tanaka, Sakae, et al.
Publicado: (2014)

The effects of once-weekly teriparatide on hip structure and biomechanical properties assessed by CT
por: Ito, M., et al.
Publicado: (2013)

Epidemiology of hip fracture in Belarus: development of a country-specific FRAX model and its comparison to neighboring country models
por: Ramanau, H., et al.
Publicado: (2018)

Osteoporosis treatment in Austria—assessment of FRAX-based intervention thresholds for high and very high fracture risk
por: Dimai, Hans P., et al.
Publicado: (2022)

Improved fracture risk prediction by adding VFA-identified vertebral fracture data to BMD by DXA and clinical risk factors used in FRAX
por: Johansson, L., et al.
Publicado: (2022)

Measures of Physical Performance and Muscle Strength as Predictors of Fracture Risk Independent of FRAX, Falls, and aBMD: A Meta‐Analysis of the Osteoporotic Fractures in Men (MrOS) Study
por: Harvey, Nicholas C, et al.
Publicado: (2018)

Study of twice-weekly injections of Teriparatide by comparing efficacy with once-weekly injections in osteoporosis patients: the TWICE study
por: Sugimoto, T., et al.
Publicado: (2019)

Effects of a single injection of teriparatide on bone turnover markers in postmenopausal women
por: Shiraki, M., et al.
Publicado: (2012)

Romosozumab efficacy on fracture outcomes is greater in patients at high baseline fracture risk: a post hoc analysis of the first year of the frame study
por: McCloskey, E. V., et al.
Publicado: (2021)

Potential Extensions of the US FRAX Algorithm
por: Melton, L. Joseph, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_s4q404fsqo61en0pn2mb7p0311